Oral Submucosal Fibrosis: A Potentially Malignant Condition to be Considered
1★, , , , , ★ Corresponding author
- 1Datta Meghe College of Pharmacy, Datta Meghe Institute of Higher Education and Research (DU), Sawangi (Meghe) Wardha, Maharashtra, INDIA.
- 3Department of Pharmaceutical Quality Assurance, R C Patel Institute of Pharmaceutical Education and Research, Shirpur, Dhule, Maharashtra, INDIA.
CORRESPONDENCE
Sukeshini Lote
Datta Meghe College of Pharmacy, Datta Meghe Institute of Higher Education and Research (DU), Sawangi (Meghe) Wardha, Maharashtra, INDIA.
Received: 06-09-2022; Revised: 15-11-2022; Accepted: 17-12-2022.
Volume 15, Issue 2 · pp. 224-232 · 2023 · DOI: 10.5530/jyp.2023.15.31
ABSTRACT
A fatal disorder named oral submucous fibrosis (OSMF) is marked by the oral submucosa's progressive fibrosis. OSMF is distinguished by aberrant collagen deposition. In 1.5–15% of patients, it’s a precancerous condition that progresses to a malignant tumour. Although nutrient deficiencies and immunological procedures could perform a role in pathogenesis, epidemiological evidence suggests that betel nut quid (which contains guvacine, arecoline, guvacoline, arecaidine, and chavibetol) contains areca nut, slaked lime, tobacco, is a significant risk factor for OSMF. Submucous fibrosis, xerostomia, ulceration, a burning sensation, and a limited mobility of the mouth are among the symptoms. The patient's quality of life is seriously affected by each of these components. The present article gives a broad overview of OSMF from a molecular viewpoint and describes what has been learned about its underlying causes, methods of diagnosis, and available treatments. Along with active therapy for OSMF, prophylaxis is essential, and this section gives a quick review of its treatment.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Lote, S., Kotkar, K., Nikam, M., Dhadiwal, Y., Zade, S., & Patil, V. (2023). Oral Submucosal Fibrosis: A Potentially Malignant Condition to be Considered. Journal of Young Pharmacists, 15(2), 224-232. https://doi.org/10.5530/jyp.2023.15.31
Copyright and licence
© 2023 Author(s)
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. CC BY-NC-SA 4.0
